Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Humacyte (HUMA) Return on Equity (2024 - 2025)

Humacyte has reported Return on Equity over the past 2 years, most recently at 142.22% for Q4 2025.

  • Quarterly results put Return on Equity at 142.22% for Q4 2025, up 14017.0% from a year ago — trailing twelve months through Dec 2025 was 142.22% (up 14017.0% YoY), and the annual figure for FY2025 was 4.71%, changed.
  • Return on Equity for Q4 2025 was 142.22% at Humacyte, down from 323.66% in the prior quarter.
  • Over the last five years, Return on Equity for HUMA hit a ceiling of 323.66% in Q3 2025 and a floor of 5.91% in Q2 2025.